GQG Partners
BSX icon

GQG Partners’s Boston Scientific BSX Stock Holding History

GQG Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-922,810
Closed -$22.9M – 53
2017
Q4 		$22.9M Buy
922,810
+319,926
+53% +$8.82M 0.72% 33
2017
Q3 		$17.6M Buy
602,884
+451,752
+299% +$12.5M 0.62% 38
2017
Q2 		$4.19M Buy
+151,132
New +$4.01M 0.31% 39

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

GQG Partners's BSX Position: Q1 2018 in Review

GQG Partners sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 922,810 shares — an estimated $22.9M sold.

GQG Partners first reported a position in BSX in Q2 2017 and held it in 3 quarters. The position peaked at $22.9M in Q4 2017. 634 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

  • GQG Partners reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
  • GQG Partners sold 922,810 Boston Scientific shares in Q1 2018, an estimated $22.9M.
  • GQG Partners first reported a position in Boston Scientific in Q2 2017 and held it in 3 quarters.
  • GQG Partners's Boston Scientific position peaked at $22.9M in Q4 2017.
  • 634 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on GQG Partners's 13F filing for Q1 2018, filed 14 May 2018.